[1] Torre LA, Siegel RL, Jemal A.Lung cancer statistics[J].Adv Exp Med Biol, 2016, 893:1-19.
[2] Chheang S, Brown K.Lung Cancer Staging: Clinical and Radiologic Perspectives [J].Seminars in Interventional Radiology, 2013, 30(2): 99-113
[3] Okayama H, Kohno T, Ishii Y,et al.Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lungadenocarcinomas.Cancer Res. 2012 Jan 1;72(1):100-11. doi: 10.1158/0008-5472.CAN-11-1403. Epub 2011 Nov 11.
[4] Meza R, Meernik C, Jeon J, et al. Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS One, 2015, Mar30;10(3): e0121323.
[5]Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol, 2015 Jul; 10(7): 990-1003.doi: 10.1097/JTO.0000000000000559.
[6] Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol, 2011, 6(2): 244-285.
[7] Xie Yuancai;Li Yun;Liu Yanguo, et al. Primary Study on Mediastinal Lymph Node Metastasis in Patients with ≤3 cm Peripheral Non-small Cell Lung Cancer.[J] Chinese Journal of Mininally Invasive Surgery,2010,l0(7):577-580.
[8] Okada M, Nishio W, Sakamoto T, et al.Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection[J].Thorac Cardiovasc Surg, 2005 Jan, 129(1): 87-93.
[9] Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1N0M0 adenocarcinoma of the lung.A predictor of lymph node metastasis. J Thorac Cardiovasc Surg, 2002, 124(2): 278-284.
[10] Junyan Zha,, Dong Xie, Huikang Xie,et al.Recognition of “aggressive” behavior in “indolent” ground glass opacity and mixed density lesions[J].J Thorac Dis 2016;8(7):1460-1468.
[11] Ningning Ding, Yousheng Mao, Shugeng Gao, et al.Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer[J].J Thorac Dis, 2018, 10(7): 4061 -4068.
[12] Haruki T, Aokage K, Miyoshi T, et al.Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection[J].J Thorac Oncol, 2015 Jun, 10(6): 930-6.
[13] Tomoshi T,Satoshi H,Shinji A,et al.Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer[J].CHEST,2007,132(1) : 170-177.
[14] Fukui T, Katayama T, Ito S, et al.Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. .2009 Dec; 66(3):309-13.[J].Lung Cancer, 2009 Dec , 66(3): 309-13.
[15] Kudo Y, Saji H, Shimada Y, et al.Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer[J].Lung Cancer, 2012 Nov, 78(2):153-60.
[16] NCCN Clinical Practice Guidelines Oncology. Non-Small Cell Lung Cancer. Version9. Available at: https://www.nccn.org/ professionals/ physician_ gls/pdf/ nscl.pdf.
[17] Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013 May;143(5 Suppl): e278S-e313S. doi: 10.1378/ chest. 12-2359.
[18] Altorki NK, Yip R, Hanaoka T, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1a lung cancer in solid nodules. J ThoracCardiovasc Surg, 2014, 147(2): 754-762; Discussion 762-754. doi:10.1016/j.jtcvs.2013.09.065.
[19] Tsutani Y, Miyata Y, Nakayama H, et al.Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage Ia lung adenocarcinoma: wedge resection or segmentectomy [J]. Chest , 2014 Jan , 145(1):66-71.
[20] Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg, 2011, 141(3): 662-670. doi:10.1016/ j.jtcvs.2010.11.008.
[21] Moon Y, Sung SW, Namkoong M, et al. The effectiveness of mediastinal lymph node evaluation in a patient with ground glass opacity tumor. J Thorac Dis, 2016, 8(9): 2617-2625. doi: 10.21037/jtd.2016.08.75.
[22] Ye B, Cheng M, Ge XX, et al.Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.World J Surg Oncol.2014 Feb 21;12:42. doi: 10.1186/1477-7819-12-42.
[23] Jiang G, Chen C, Zhu Y, et al. Shanghai Pulmonary Hospital Experts Consensus on the
Management of Ground-Glass Nodules Suspected as Lung Adenocarcinoma (Version 1).
Zhongguo Fei Ai Za Zhi.2018; 21(3):147-159. doi: 10.3779/j.issn. 1009- 3419. 2018.03.05.